Summary: Donation of CCP, Blood Components and HCT/Ps, Including Information on COVID-19 Vaccines or Treatment with CCP or Monoclonals (updated 04/14/21)
This section contains information on questionnaires used to screen prospective donors and help ensure the safety of the donation process as well as the product being donated. AABB has played a leadership role in the development of model questionnaires for blood collection facilities as well as for facilities involved in the collection of hematopoietic progenitor cells (HPCs).
Iceland to End Indefinite Donor Deferral of Gay, Bisexual Men
September 14, 2021
Israel Ends Deferral Period for Some MSM Donors
August 25, 2021
Revised Donor Eligibility Process Takes Effect in Northern Ireland
August 20, 2021